Primary malignant mesothelioma of the diaphragm with liver invasion: A case report and review of literature
- PMID: 30985689
- PMCID: PMC6485870
- DOI: 10.1097/MD.0000000000015147
Primary malignant mesothelioma of the diaphragm with liver invasion: A case report and review of literature
Erratum in
-
Primary malignant mesothelioma of the diaphragm with liver invasion: A case report and review of literature: Erratum.Medicine (Baltimore). 2019 May;98(19):e15667. doi: 10.1097/MD.0000000000015667. Medicine (Baltimore). 2019. PMID: 31083271 Free PMC article. No abstract available.
Abstract
Rationale: Malignant mesothelioma is a malignant tumor with poor prognosis, which usually originates in the pleura, peritoneum, and pericardial cavity. Mesotheliomas that originate from the diaphragm are very rare. Here, we report a case of primary malignant mesothelioma of the diaphragm with liver invasion.
Patient concerns: A 66-year-old woman was admitted to our hospital because of a "liver space-occupying lesion," without any special clinical symptoms. Imaging examinations suggested a cystic-solid mixed lesion in the right lobe of the liver.
Diagnosis: The tumor was diagnosed as epithelioid mesothelioma of the diaphragm with liver invasion.
Intervention: The patient underwent abdominal surgery in our hospital to remove the diaphragmatic mass, liver mass, and part of the diaphragm.
Outcomes: The postoperative course was uneventful.
Lessons: Primary diaphragmatic malignant mesothelioma is very rare and may involve liver or lung tissue and be mistaken for liver or lung tumor. Accurate diagnosis depends on careful pathological examination. Immunohistochemical staining is very useful to distinguish this tumor from other liver or diaphragmatic tumors.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- McCroskey Z, Staerkel G, Roy-Chowdhuri S. Utility of BRCA1-associated protein 1 immunoperoxidase stain to differentiate benign versus malignant mesothelial proliferations in cytologic specimens. Diagn Cytopathol 2017;45:312–9. - PubMed
-
- Wu D, Hiroshima K, Yusa T, et al. Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma. Ann Diagn Pathol 2017;26:31–7. - PubMed
-
- An YX, Wei LX. Malignant mesothelioma clinicopathological analyses of 100 cases. Zhen Duan Bing Li Xue Za Zhi 2015;22:156–8. (Chinese).
-
- Zhang Y, Gu YH. One case of diffuse high differentiated papillary mesothelioma of the peritoneum. Zhen Duan Bing Li Xue Za Zhi 2018;06:457–9. (Chinese).
-
- Schunselaar LM, Zwart W, Baas P. Targeting BAP1: a new paradigm for mesothelioma. Lung Cancer 2017;109:145–6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
